Aug 2026
In silico investigation of novel isatin derivatives as potential multi-target anticancer agents targeting VEGFR-2, EGFR, and caspase-6.
This study highlights the usefulness of computational approaches in the discovery of novel isatin-based multi-target lead candidates for cancer therapy and suggests that compound 4 represents a promising lead for further investigation.
Vipul Kumar, Vivek Kumar, P. C. Sharma et al.
· Journal of Receptor and Sign... · 0 citations